Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
NCT04225260
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
902
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Lateral Canthal Lines
Interventions
BIOLOGICAL:
botulinum toxin neuromodulator
Sponsor
Galderma R&D